十四烷酸癸酯 | 41927-71-3

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 十四烷酸癸酯
• 中文别名: 肉豆蔻酸癸酯
• 英文名称: Decyl myristate
• 英文别名: decyl tetradecanoate
• CAS: 41927-71-3
• 化学式: C₂₄H₄₈O₂
• 分子量: 368.6
• InChiKey: BOUIEBMBWBCUPB-UHFFFAOYSA-N

物化性质

• LogP：
  10.975 (est)
• 保留指数：
  2555

计算性质

• 辛醇/水分配系数(LogP)：
  10.9
• 重原子数：
  26
• 可旋转键数：
  22
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.96
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2915900090

文献信息

• DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF
  申请人：RNS CO.,LTD.

  公开号：US20150283051A1

  公开（公告）日：2015-10-08

  Provided is a skin whitening composition with excellent whitening effects, specifically, a derivative or a polyhydroxy cyclic compound represented by Formula I or a pharmacologically acceptable salt thereof, comprising; wherein is derived from an aromatic cyclic compound, C n , C n+1 and C n+2 are three neighboring carbon atoms present in the aromatic cyclic compound, wherein n is a positive integer, R 1 and R 2 are each a saturated or unsaturated straight or branched alkyl or acyl group having 3 to 12 carbon atoms, and R 3 , R 4 , R 5 and R 6 are each independently at least one substituent selected from hydrogen, alkyl, alkoxy, acyloxy, acyloxymethyl, oxo, hydroxy, vinyl, nitrile, carboxaldehyde, carbonitrile and aldehyde.

  提供一个具有优异美白效果的皮肤美白组合物，具体为公式I所表示的衍生物或多元醇环化合物或其药理上可接受的盐，其中 所述的芳香族环化合物，C n ，C n+1 和C n+2 是存在于芳香族环化合物中的三个相邻的碳原子，其中n是正整数，R 1 和R 2 分别是具有3至12个碳原子的饱和或不饱和直链或支链烷基或酰基，而R 3 ，R 4 ，R 5 和R 6 各自独立地选自氢、烷基、烷氧基、酰氧基、酰氧甲基、氧代、羟基、乙烯基、腈、羧醛、碳腈和醛中至少一个取代基。
• [EN] NOVEL ANTIMICROBIAL PEPTIDES AND THEIR APPLICATION<br/>[FR] NOUVEAUX PEPTIDES ANTIMICROBIENS ET LEUR APPLICATION
  申请人：INFINITEC ACTIVOS S L

  公开号：WO2015135896A1

  公开（公告）日：2015-09-17

  The present invention relates to a compound of formula (I) and to compositions comprising said compound, as well as the use of said compound and/or said compositions to prevent fungal and/or bacterial growth.

  本发明涉及式(I)的化合物，以及包含该化合物的组合物，以及使用该化合物和/或所述组合物来防止真菌和/或细菌生长。
• [EN] METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR<br/>[FR] PROCÉDÉ DE MODULATION DE L'ACTIVITÉ DU RÉCEPTEUR MC1 ET TRAITEMENT DES CONDITIONS ASSOCIÉES AU DIT RÉCEPTEUR
  申请人：MIMETICA PTY LTD

  公开号：WO2010096853A1

  公开（公告）日：2010-09-02

  The present invention provides compounds of Formula (I) that are useful for binding and/or modulating the biological activity of the melanocortin-1 receptor (MC1R). Compounds of this invention can be used to treat diseases and/or conditions in which modulation of MC1R is beneficial. Such diseases and/or conditions include, but are not limited to, hyperpigmentation (including melasma), hypopigmentation (including vitiligo), melanoma, basal cell carcinoma, squamous cell carcinoma, erythropoietic protoporphyria, polymorphous light eruption, solar urticaria, photosensitivity, sunburn, inflammatory diseases, aberrant fibroblast activity and pain.

  本发明提供了一种具有式（I）的化合物，该化合物对结合和/或调节黑色素皮质素-1受体（MC1R）的生物活性是有用的。本发明的化合物可用于治疗调节MC1R有益的疾病和/或症状。这些疾病和/或症状包括但不限于，色素沉着过多（包括雀斑），色素沉着不足（包括白癜风），黑色素瘤，基底细胞癌，鳞状细胞癌，红细胞生成性原卟啉症，多形性光疹，太阳性荨麻疹，光敏性，晒伤，炎症性疾病，异常成纤维细胞活动和疼痛。
• [EN] METHODS OF MODULATING THE ACTIVITY OF THE MC3 AND/OR MC4 RECEPTORS AND TREATMENT OF CONDITIONS RELATED TO THESE RECEPTORS<br/>[FR] PROCÉDÉS DE MODULATION DE L'ACTIVITÉ DES RÉCEPTEURS MC3 ET/OU MC4 ET TRAITEMENT DES CONDITIONS ASSOCIÉES AUX DITS RÉCEPTEURS
  申请人：MIMETICA PTY LTD

  公开号：WO2010096854A1

  公开（公告）日：2010-09-02

  The present invention provides compounds of Formula (I) that are useful for modulating the biological activity of the melanocortin-3 receptor (MC3R) and / or the melanocortin-4 receptor (MC4R). Compounds of this invention can be used to treat diseases and/or conditions in which modulation of MC3R and / or MC4R is beneficial. Such diseases and/or conditions include, but are not limited to, obesity, eating disorders (such as cachexia, anorexia, weight gain, weight loss), metabolic syndrome, diabetes, sexual dysfunction (such as erectile dysfunction and female sexual dysfunction), anxiety, depression, inflammation, addiction and alcohol intake.

  本发明提供了一种化合物，其化学式为（I），可用于调节黑色素皮质素-3受体（MC3R）和/或黑色素皮质素-4受体（MC4R）的生物活性。本发明的化合物可用于治疗调节MC3R和/或MC4R有益的疾病和/或症状。这些疾病和/或症状包括但不限于肥胖、进食障碍（如虚弱、厌食、体重增加、体重减少）、代谢综合征、糖尿病、性功能障碍（如勃起功能障碍和女性性功能障碍）、焦虑、抑郁、炎症、成瘾和饮酒。
• METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR
  申请人：Blaskovich Mark Arnold Thomas

  公开号：US20120141392A1

  公开（公告）日：2012-06-07

  The present invention provides compounds of Formula (I) that are useful for binding and/or modulating the biological activity of the melanocortin-1 receptor (MC1R). Compounds of this invention can be used to treat diseases and/or conditions in which modulation of MC1R is beneficial. Such diseases and/or conditions include, but are not limited to, hyperpigmentation (including melasma), hypopigmentation (including vitiligo), melanoma, basal cell carcinoma, squamous cell carcinoma, erythropoietic protoporphyria, polymorphous light eruption, solar urticaria, photosensitivity, sunburn, inflammatory diseases, aberrant fibroblast activity and pain.

  本发明提供了一种化合物，其化学式为（I），可用于结合和/或调节黑色素皮质激素受体（MC1R）的生物活性。本发明的化合物可用于治疗调节MC1R有益的疾病和/或症状。这些疾病和/或症状包括但不限于，色素沉着过多（包括雀斑），色素沉着不足（包括白癜风），黑色素瘤，基底细胞癌，鳞状细胞癌，红细胞生成性原卟啉症，多形性光疹，太阳性荨麻疹，光敏性，晒伤，炎症性疾病，异常成纤维细胞活性和疼痛。